$PFE News Apple looks ready to head higher 3:48
Post# of 44960
Posted On: 03/25/2014 10:30:02 AM
$PFE News
Apple looks ready to head higher 3:48 p.m. March 17, 2014 - blogs.marketwatch.com
Apple as the Comeback Kid 1:13 p.m. March 13, 2014 - Mark Hulbert
Mylan to start selling generic Celebrex in May 7:22 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - blogs.marketwatch.com
Pfizer loses ruling on Celebrex patent dispute 2:46 p.m. March 12, 2014 - Russ Britt
Trading resumes on Pfizer shares 2:37 p.m. March 12, 2014 - Russ Britt
Ruling invalidates Pfizer's Celebrex patent 2:36 p.m. March 12, 2014 - Russ Britt
Pfizer obtained reissue patent on Celebrex in 2013 2:35 p.m. March 12, 2014 - Russ Britt
Pfizer plans to appeal ruling on Celebrex judgment 2:31 p.m. March 12, 2014 - Russ Britt
Pfizer loses ruling on Celebrex patent dispute 2:30 p.m. March 12, 2014 - Russ Britt
Pfizer halted 2:15 p.m. March 12, 2014 - Steve Goldstein
S&P 500 extends the break to ‘clear skies’ territory 10:46 a.m. March 6, 2014 - Michael Ashbaugh
Newscast: Stocks take a spill to start the week 4:26 p.m. March 3, 2014 - MarketWatch
Pfizer aims to sell over-the-counter version of Lipitor 8:13 a.m. March 3, 2014 - Peter Loftus
Newscast: Pfizer moves to make Lipitor OTC 7:39 a.m. March 3, 2014 - MarketWatch
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
Pfizer pneumonia vaccine study meets objectives 7:45 a.m. Feb. 24, 2014 - MarketWatch.com
You'd have to be a dope to buy marijuana stocks 1:36 p.m. Feb. 13, 2014 - blogs.marketwatch.com
Australia regulator takes action against Pfizer 11:03 p.m. Feb. 12, 2014 - MarketWatch.com
Pfizer, GE, Boeing lead early Dow advancers 9:34 a.m. Feb. 11, 2014 - William L. Watts
Pfizer Cancer Drug Xalkori Shows Positive Results as First-Line Remedy 9:15 a.m. Today - The Wall Street Journal Interactive Edition
Pfizer's Xalkori lung-cancer drug performs well in another Phase III 8:48 a.m. Today - Seeking Alpha
Top Stock Picks From an Index-Crushing Manager 6:58 a.m. Today - Barrons.com
Pfizer: 4 Different Insiders Have Sold Shares This Month 3:06 a.m. Today - Seeking Alpha
U.S. Stocks Decline 7:03 p.m. March 24, 2014 - The Wall Street Journal Interactive Edition
The 4 Stocks That Pushed Stocks Lower on Monday 3:08 p.m. March 24, 2014 - 247WallSt.com
Interesting April Stock Options For PFE 11:59 a.m. March 24, 2014 - TheStreet.com
PFE July 19th Options Begin Trading 11:55 a.m. March 24, 2014 - TheStreet.com
Breakthrough Therapy Status for Pfizer's Drug - Analyst Blog 11:30 a.m. March 24, 2014 - Zacks.com
Top 10 Dow Dividend Stocks for March 5:35 a.m. March 24, 2014 - InvestorPlace.com
A Dividend Investing History Lesson - Pfizer And FirstEnergy Corporation 5:28 p.m. March 23, 2014 - Seeking Alpha
Proposed Law Would Require More Drug-Trial Transparency 5:01 p.m. March 21, 2014 - The Wall Street Journal Interactive Edition
The 5 Stocks That Sank Markets on Friday 3:28 p.m. March 21, 2014 - 247WallSt.com
March Madness: Final Four Investing Bracket 2014 6:36 p.m. March 20, 2014 - Seeking Alpha
Recent Trials Could Help Pfizer Solidify Its Dominance In Pneumococcal Vaccine Market 4:11 p.m. March 20, 2014 - Seeking Alpha
Glaxo's Stock May Suffer Drowsiness 2:22 p.m. March 20, 2014 - The Wall Street Journal Interactive Edition
Pfizer meningococcal disease vaccine gets breakthrough designation 8:56 a.m. March 20, 2014 - Seeking Alpha
Should You Take a Chance With Novartis? 3:52 p.m. March 19, 2014 - Wall St. Cheat Sheet
Why Pfizer's Debt Levels Should Be Of Little Concern 12:10 p.m. March 19, 2014 - Seeking Alpha
Insider Trading Alert - PFE, WOOF And BOBE Traded By Insiders 11:15 a.m. March 19, 2014 - TheStreet.com
Pfizer Reports Positive Phase 3 Study Outcome Of XALKORI® (crizotinib) Compared To Chemotherapy In Previously Untreated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) 8:30 a.m. Today - BusinessWire - BZX
Renaissance Technologies Buys Stake in Pfizer; Yahoo Looks to Profit from Alibaba IPO 12:21 a.m. Today - ACCESSWIRE
Pfizer Announces Detailed Results of OPT Compare Phase 3 Study of Tofacitinib 5 mg and 10 mg Twice Daily Compared to High-Dose ENBREL® in Adults with Moderate-to-Severe Chronic Plaque Psoriasis 11:45 a.m. March 22, 2014 - BusinessWire - BZX
Healthcare Companies Report Acquisitions, Upcoming Results Schedules, Dividends, and Annual Reviews - Analyst Notes on Pfizer, Magellan Health Services, Prothena, Alere, and KYTHERA 8:00 a.m. March 21, 2014 - PR Newswire - PRF
Pfizer’s Investigational Vaccine Candidate Bivalent rLP2086 Receives U.S. Food and Drug Administration Breakthrough Therapy Designation for Potential Prevention of Meningococcal B Disease 8:31 a.m. March 20, 2014 - BusinessWire - BZX
Healthcare Companies Report FDA Approvals, Comprehensive Analysis, Schedules, and Stock Movements - Analyst Notes on Pfizer, Johnson & Johnson, Biogen, Express Scripts, and Forest Laboratories 8:00 a.m. March 20, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Appointment of Mark Corrigan to Board of Directors 4:00 p.m. March 19, 2014 - PR Newswire - PRF
ViiV Healthcare Announces Next Round of the Positive Action Southern Initiative to Support Linkages to HIV/AIDS Care and Treatment Adherence 9:45 a.m. March 19, 2014 - PR Newswire - PRF
Insider Trading Research - Alerts for Microsoft, Oracle, Pfizer, Plug Power, Sirius XM, and Bank of America 8:55 a.m. March 19, 2014 - PR Newswire - PRF
Portola Pharmaceuticals Initiates Phase 3 Study of Andexanet Alfa, Potential First-in-Class Factor Xa Inhibitor Reversal Agent, Under Accelerated Approval Pathway 8:15 a.m. March 19, 2014 - GlobeNewswire
Pfizer Launches 2013 Integrated Annual Review 10:00 a.m. March 18, 2014 - BusinessWire - BZX
Healthcare Companies Receive Approvals, Recognitions, Agreements, and Announce Senior Level Appointments- Analyst Notes on Pfizer, Boston Scientific, WellPoint, Aetna, and Humana 8:00 a.m. March 18, 2014 - PR Newswire - PRF
U.S. FDA Approves Eliquis® (apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery 1:00 p.m. March 14, 2014 - BusinessWire - BZX
Insider Trading Alert - Research Report on Facebook, Intel, Yahoo, Plug Power, FuelCell Energy, and Pfizer 8:55 a.m. March 14, 2014 - PR Newswire - PRF
Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent 2:28 p.m. March 12, 2014 - BusinessWire - BZX
Pfizer Announces Webcast Of April 6 Conference Call With Securities Analysts To Review Palbociclib Phase 2 Final Results Following Presentation At AACR Annual Meeting 2014 10:01 a.m. March 12, 2014 - BusinessWire - BZX
Pfizer Presents Detailed Results From Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA)Evaluating Efficacy Of Prevenar 13* 6:37 a.m. March 12, 2014 - BusinessWire - BZX
American DG Energy and Pepco Well Positioned as Coke eBay and More Employ Cogeneration Systems 10:08 a.m. March 11, 2014 - ACCESSWIRE
Pfizer Initiates Nationwide Voluntary Recall of Two Lots of Pfizer’s Effexor XR® 150 Mg Extended-Release Capsules and One Lot of Greenstone’s Venlafaxine HCl 150 Mg Extended-Release Capsules Due to the Possible Presence of Tikosyn® Capsules 5:15 p.m. March 6, 2014 - BusinessWire - BZX
Morning Briefing - 52-Weeks High Breakers: Wells Fargo, Corning, Delta Air Lines and Pfizer 12:16 p.m. March 6, 2014 - PR Newswire - PRF
Apple looks ready to head higher 3:48 p.m. March 17, 2014 - blogs.marketwatch.com
Apple as the Comeback Kid 1:13 p.m. March 13, 2014 - Mark Hulbert
Mylan to start selling generic Celebrex in May 7:22 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - blogs.marketwatch.com
Pfizer loses ruling on Celebrex patent dispute 2:46 p.m. March 12, 2014 - Russ Britt
Trading resumes on Pfizer shares 2:37 p.m. March 12, 2014 - Russ Britt
Ruling invalidates Pfizer's Celebrex patent 2:36 p.m. March 12, 2014 - Russ Britt
Pfizer obtained reissue patent on Celebrex in 2013 2:35 p.m. March 12, 2014 - Russ Britt
Pfizer plans to appeal ruling on Celebrex judgment 2:31 p.m. March 12, 2014 - Russ Britt
Pfizer loses ruling on Celebrex patent dispute 2:30 p.m. March 12, 2014 - Russ Britt
Pfizer halted 2:15 p.m. March 12, 2014 - Steve Goldstein
S&P 500 extends the break to ‘clear skies’ territory 10:46 a.m. March 6, 2014 - Michael Ashbaugh
Newscast: Stocks take a spill to start the week 4:26 p.m. March 3, 2014 - MarketWatch
Pfizer aims to sell over-the-counter version of Lipitor 8:13 a.m. March 3, 2014 - Peter Loftus
Newscast: Pfizer moves to make Lipitor OTC 7:39 a.m. March 3, 2014 - MarketWatch
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
Pfizer pneumonia vaccine study meets objectives 7:45 a.m. Feb. 24, 2014 - MarketWatch.com
You'd have to be a dope to buy marijuana stocks 1:36 p.m. Feb. 13, 2014 - blogs.marketwatch.com
Australia regulator takes action against Pfizer 11:03 p.m. Feb. 12, 2014 - MarketWatch.com
Pfizer, GE, Boeing lead early Dow advancers 9:34 a.m. Feb. 11, 2014 - William L. Watts
Pfizer Cancer Drug Xalkori Shows Positive Results as First-Line Remedy 9:15 a.m. Today - The Wall Street Journal Interactive Edition
Pfizer's Xalkori lung-cancer drug performs well in another Phase III 8:48 a.m. Today - Seeking Alpha
Top Stock Picks From an Index-Crushing Manager 6:58 a.m. Today - Barrons.com
Pfizer: 4 Different Insiders Have Sold Shares This Month 3:06 a.m. Today - Seeking Alpha
U.S. Stocks Decline 7:03 p.m. March 24, 2014 - The Wall Street Journal Interactive Edition
The 4 Stocks That Pushed Stocks Lower on Monday 3:08 p.m. March 24, 2014 - 247WallSt.com
Interesting April Stock Options For PFE 11:59 a.m. March 24, 2014 - TheStreet.com
PFE July 19th Options Begin Trading 11:55 a.m. March 24, 2014 - TheStreet.com
Breakthrough Therapy Status for Pfizer's Drug - Analyst Blog 11:30 a.m. March 24, 2014 - Zacks.com
Top 10 Dow Dividend Stocks for March 5:35 a.m. March 24, 2014 - InvestorPlace.com
A Dividend Investing History Lesson - Pfizer And FirstEnergy Corporation 5:28 p.m. March 23, 2014 - Seeking Alpha
Proposed Law Would Require More Drug-Trial Transparency 5:01 p.m. March 21, 2014 - The Wall Street Journal Interactive Edition
The 5 Stocks That Sank Markets on Friday 3:28 p.m. March 21, 2014 - 247WallSt.com
March Madness: Final Four Investing Bracket 2014 6:36 p.m. March 20, 2014 - Seeking Alpha
Recent Trials Could Help Pfizer Solidify Its Dominance In Pneumococcal Vaccine Market 4:11 p.m. March 20, 2014 - Seeking Alpha
Glaxo's Stock May Suffer Drowsiness 2:22 p.m. March 20, 2014 - The Wall Street Journal Interactive Edition
Pfizer meningococcal disease vaccine gets breakthrough designation 8:56 a.m. March 20, 2014 - Seeking Alpha
Should You Take a Chance With Novartis? 3:52 p.m. March 19, 2014 - Wall St. Cheat Sheet
Why Pfizer's Debt Levels Should Be Of Little Concern 12:10 p.m. March 19, 2014 - Seeking Alpha
Insider Trading Alert - PFE, WOOF And BOBE Traded By Insiders 11:15 a.m. March 19, 2014 - TheStreet.com
Pfizer Reports Positive Phase 3 Study Outcome Of XALKORI® (crizotinib) Compared To Chemotherapy In Previously Untreated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) 8:30 a.m. Today - BusinessWire - BZX
Renaissance Technologies Buys Stake in Pfizer; Yahoo Looks to Profit from Alibaba IPO 12:21 a.m. Today - ACCESSWIRE
Pfizer Announces Detailed Results of OPT Compare Phase 3 Study of Tofacitinib 5 mg and 10 mg Twice Daily Compared to High-Dose ENBREL® in Adults with Moderate-to-Severe Chronic Plaque Psoriasis 11:45 a.m. March 22, 2014 - BusinessWire - BZX
Healthcare Companies Report Acquisitions, Upcoming Results Schedules, Dividends, and Annual Reviews - Analyst Notes on Pfizer, Magellan Health Services, Prothena, Alere, and KYTHERA 8:00 a.m. March 21, 2014 - PR Newswire - PRF
Pfizer’s Investigational Vaccine Candidate Bivalent rLP2086 Receives U.S. Food and Drug Administration Breakthrough Therapy Designation for Potential Prevention of Meningococcal B Disease 8:31 a.m. March 20, 2014 - BusinessWire - BZX
Healthcare Companies Report FDA Approvals, Comprehensive Analysis, Schedules, and Stock Movements - Analyst Notes on Pfizer, Johnson & Johnson, Biogen, Express Scripts, and Forest Laboratories 8:00 a.m. March 20, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Appointment of Mark Corrigan to Board of Directors 4:00 p.m. March 19, 2014 - PR Newswire - PRF
ViiV Healthcare Announces Next Round of the Positive Action Southern Initiative to Support Linkages to HIV/AIDS Care and Treatment Adherence 9:45 a.m. March 19, 2014 - PR Newswire - PRF
Insider Trading Research - Alerts for Microsoft, Oracle, Pfizer, Plug Power, Sirius XM, and Bank of America 8:55 a.m. March 19, 2014 - PR Newswire - PRF
Portola Pharmaceuticals Initiates Phase 3 Study of Andexanet Alfa, Potential First-in-Class Factor Xa Inhibitor Reversal Agent, Under Accelerated Approval Pathway 8:15 a.m. March 19, 2014 - GlobeNewswire
Pfizer Launches 2013 Integrated Annual Review 10:00 a.m. March 18, 2014 - BusinessWire - BZX
Healthcare Companies Receive Approvals, Recognitions, Agreements, and Announce Senior Level Appointments- Analyst Notes on Pfizer, Boston Scientific, WellPoint, Aetna, and Humana 8:00 a.m. March 18, 2014 - PR Newswire - PRF
U.S. FDA Approves Eliquis® (apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery 1:00 p.m. March 14, 2014 - BusinessWire - BZX
Insider Trading Alert - Research Report on Facebook, Intel, Yahoo, Plug Power, FuelCell Energy, and Pfizer 8:55 a.m. March 14, 2014 - PR Newswire - PRF
Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent 2:28 p.m. March 12, 2014 - BusinessWire - BZX
Pfizer Announces Webcast Of April 6 Conference Call With Securities Analysts To Review Palbociclib Phase 2 Final Results Following Presentation At AACR Annual Meeting 2014 10:01 a.m. March 12, 2014 - BusinessWire - BZX
Pfizer Presents Detailed Results From Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA)Evaluating Efficacy Of Prevenar 13* 6:37 a.m. March 12, 2014 - BusinessWire - BZX
American DG Energy and Pepco Well Positioned as Coke eBay and More Employ Cogeneration Systems 10:08 a.m. March 11, 2014 - ACCESSWIRE
Pfizer Initiates Nationwide Voluntary Recall of Two Lots of Pfizer’s Effexor XR® 150 Mg Extended-Release Capsules and One Lot of Greenstone’s Venlafaxine HCl 150 Mg Extended-Release Capsules Due to the Possible Presence of Tikosyn® Capsules 5:15 p.m. March 6, 2014 - BusinessWire - BZX
Morning Briefing - 52-Weeks High Breakers: Wells Fargo, Corning, Delta Air Lines and Pfizer 12:16 p.m. March 6, 2014 - PR Newswire - PRF
(0)
(0)